A message from NAC International

NAC International Showcases Capabilities as Supplier for SMR and AR Developers

Astatine-211 targets blood-borne cancers in Seattle clinical trials

September 13, 2022, 9:30AMNuclear News

A clinical dose of At-211 is prepared at the University of Washington for use in a Fred Hutchison Cancer Center clinical trial. (Photo: UW/Don Hamlin)

Scientists in the Departments of Radiation Oncology and Medicine at the University of Washington (UW) and Fred Hutchinson Cancer Center (Fred Hutch) are directly targeting cancerous cells traveling through patients’ bloodstreams with diseases such as leukemia and lymphoma using an intravenous injection of the radioactive isotope astatine-211 (At-211). The work, its challenges, and its promise were described in a recent news release from the National Isotope Development Center (NIDC), which is managed by the Department of Energy’s Isotope Program.

To continue reading, log in or create a free account!

With $3.4 billion to spend, the DOE opens RFP for low-enriched uranium

June 28, 2024, 12:01PMNuclear News

The Department of Energy released an anticipated request for proposals on June 27 for low-enriched uranium enrichment. “Today’s action will help spur the safe and responsible build-out of...

ANS Annual Conference: Nuclear waste

June 27, 2024, 3:03PMNuclear News

With increasing demand for clean, reliable, and safe sources of energy, the conversation around nuclear energy is changing. And so too is the conversation around nuclear waste, even as the...

Durable gallium-based transistors could improve reactor monitoring

June 27, 2024, 9:30AMNuclear News

Researchers at the Department of Energy’s Oak Ridge National Laboratory want to make the sensors in nuclear power plants more accurate by linking them to electronics that can withstand the...

GAIN vouchers tackle LWR risk modeling and advanced reactor fuel salts

June 27, 2024, 7:00AMNuclear News

The Department of Energy’s Gateway for Accelerated Innovation in Nuclear (GAIN) announced June 20 that two companies—one power plant operator and one advanced reactor developer—are...

Simulated radiological release tests SRS response teams

June 26, 2024, 3:00PMNuclear News

Earlier this month, nearly 250 personnel at the Department of Energy’s Savannah River Site in South Carolina took part in an annual exercise to test preparedness for a radiological release...

DOE approves safety design strategy for Radiant microreactor test plan

June 12, 2024, 12:01PMNuclear News

Radiant Industries announced on June 4 that the safety design strategy (SDS) for a test of its Kaleidos microreactor in the National Reactor Innovation Center’s DOME test bed at Idaho...

Past DOE officials reflect on their tenures and future of nuclear industry

June 10, 2024, 3:04PMANS News

At the “Past Department of Energy Nuclear Energy Officials Roundtable” webinar on May 20, the American Nuclear Society gathered six past assistant secretaries for the Office of Nuclear...

New fusion energy strategies and partnerships announced at White House event

June 10, 2024, 12:00PMNuclear News

Just one week after the White House Office of Science and Technology Policy hosted a summit on domestic nuclear deployment, they filled a room again on June 6 for a livestreamed event cohosted...

DOE announces first clean energy project for INL

June 10, 2024, 9:31AMRadwaste Solutions

The Department of Energy will enter into lease negotiations with two solar energy developers for 400 megawatts of solar electricity generation within the Idaho National Laboratory site....

Oklo’s Diané presents at Community of Practice

June 10, 2024, 7:00AMANS News

The American Nuclear Society’s Risk-informed, Performance-based Principles and Policy Committee (RP3C) held another Community of Practice (CoP) on April 26. For this event, the committee...

Astatine-211 targets blood-borne cancers in Seattle clinical trials

Related Articles